EUVIMEDEUVIMED entdecken
Open Access

Switch to Integrase Strand Transfer Inhibitors During the Menopausal Transition Is Associated With Accelerated Body Composition Change in Women With HIV

Rebecca A Abelman iD, Yifei Ma, C Christina Mehta, Qian Yang iD, Fan Xia, James B Brock, Maria Alcaide, Anjali Sharma, Michelle Floris-Moore iD, Elizabeth Topper, Kathleen M Weber, Seble G Kassaye und 4 weitere

Clinical Infectious Diseases · 04.06.2025 · 80 (5) · 1125-1132

DOI: 10.1093/cid/ciae540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 04.11.2024. Verfasst von Rebecca A Abelman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: HIV Infections, Menopause, Body Composition, HIV Integrase Inhibitors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Integrase strand transfer inhibitors (INSTIs) and the menopausal transition have been associated with body composition changes in women with human immunodeficiency virus (WWH), but their interaction is unknown.

Methods

From 2006 to 2019, 1131 virally-suppressed WWH (419 who switched to INSTI [INSTI+]; 712 who did not switch [INSTI–]) and 887 women without HIV (WWOH) from the Women's Interagency HIV Study were included. Mixed-effects models were used to evaluate change in waist circumference (WC) and body mass index (BMI) by menopausal phase defined using anti-Müllerian hormone, a biomarker of ovarian reserve.

Results

During premenopause, WWH had increases in WC (INSTI+: 0.01 cm per 6 months [95% confidence interval {CI}: −.29 to .32] and INSTI−: 0.22 cm per 6 months [95% CI: −.01 to .44]) that were not statistically significantly different from WWOH; there was also little difference by INSTI status. In late perimenopause, INSTI+ had faster increases in WC (0.37 cm per 6 months [95% CI: .15–.60]) while INSTI− had smaller increases (0.14 cm per 6 months [95% CI: −.06 to .34]) compared to WWOH. In menopause, INSTI+ had faster increases, peaking at 43 months then declining, while INSTI− had smaller increases (0.14 cm per 6 months [95% CI: −.02 to .30]). Compared to INSTI−, in late perimenopause, INSTI+ had 0.26 cm per 6 months (95% CI: .02–.50) faster linear increases in WC and in menopause, INSTI+ was associated with faster increases, peaking at 41 months.

Conclusions

Switching to an INSTI-based regimen during late perimenopause and menopause is associated with faster increases in WC when compared to women who did not switch. Menopausal status should be considered when switching to an INSTI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsMenopauseBody CompositionHIV Integrase InhibitorsHumansFemaleMiddle AgedAdultBody Mass IndexWaist Circumference

Stichwörter der Autor:innen

ARTBMIHIVmenopausewaist circumference

Substanzen

HIV Integrase Inhibitors

Autor:innen und Institutionen

  • Department of Medicine, University of California, San Francisco, California, USA.
  • Medical Service, San Francisco Veteran Affairs Health Care System, California, USA.
  • Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
  • Department of Medicine, Miller School of Medicine, University of Miami, Florida, USA.
  • Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.

ORCID-Profile: Rebecca A Abelman, Qian Yang, Michelle Floris-Moore, Deborah Gustafson, Cecile D Lahiri, Phyllis C Tien

Förderung

  • NIA NIH HHS
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Abelman, R. A., Ma, Y., Mehta, C. C., Yang, Q., Xia, F., Brock, J. B., Alcaide, M., Sharma, A., Floris-Moore, M., Topper, E., Weber, K. M., Kassaye, S. G., Gustafson, D., Grunfeld, C., Lahiri, C. D., & Tien, P. C. (2025). Switch to Integrase Strand Transfer Inhibitors During the Menopausal Transition Is Associated With Accelerated Body Composition Change in Women With HIV. Clinical Infectious Diseases, 80(5), 1125-1132. https://doi.org/10.1093/cid/ciae540

Vancouver

Abelman RA, Ma Y, Mehta CC, Yang Q, Xia F, Brock JB, et al. Switch to Integrase Strand Transfer Inhibitors During the Menopausal Transition Is Associated With Accelerated Body Composition Change in Women With HIV. Clinical Infectious Diseases. 2025;80(5):1125-1132. doi:10.1093/cid/ciae540

BibTeX
@article{Abelman2025,
  author = {Abelman, Rebecca A and Ma, Yifei and Mehta, C Christina and Yang, Qian and Xia, Fan and Brock, James B and Alcaide, Maria and Sharma, Anjali and Floris-Moore, Michelle and Topper, Elizabeth and Weber, Kathleen M and Kassaye, Seble G and Gustafson, Deborah and Grunfeld, Carl and Lahiri, Cecile D and Tien, Phyllis C},
  title = {Switch to Integrase Strand Transfer Inhibitors During the Menopausal Transition Is Associated With Accelerated Body Composition Change in Women With HIV},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  volume = {80},
  number = {5},
  pages = {1125--1132},
  doi = {10.1093/cid/ciae540}
}
Kostenlos starten →